This contract involves the procurement of ultrasound machines with probes for various services at HFAR-PP and HFAR-PL. The total value of the contract is €290,000. The deadline for submitting bids is January 29, 2026. This opportunity is published on the TED platform and is managed by the General St
Tender closed on 29 Jan 2026. Awaiting award.
This contract is for the procurement of heavy medical imaging equipment intended for use in healthcare, dental, and veterinary services. The buyer, the General Staff of the Armed Forces (EMGFA), is seeking suppliers who can provide high-quality imaging technology. The total value of the contract is
The Estado-Maior-General das Forças Armadas (EMGFA) is seeking suppliers for surgical equipment intended for operating rooms. This procurement opportunity is valued at €1,374,000 and is part of a health sector initiative. Suppliers are invited to submit their proposals by February 1, 2026. For more
This contract opportunity is for the supply of surgical equipment specifically intended for a military toxicology unit in Portugal. The total value of the contract is €534,000. Suppliers are invited to provide the necessary equipment that meets the specifications outlined in the tender. The deadline
This contract opportunity involves the procurement of articulated hospital beds for the inpatient services of the Armed Forces Hospital, specifically for the Porto and Lisbon locations. The total value of the contract is €330,000. Suppliers are invited to submit their bids by January 29, 2026. For m
Multi-supplier framework opportunity to supply and install medical equipment and healthcare products for a new nursing skills laboratory and clinical ward training facility in Tipperary.
Lead Provider needed to deliver and expand Mental Health Support Teams across South West London, managing 25 teams with contract value of £89.9m over three years from April 2027.
Supply of PET-CT radiopharmaceuticals to support diagnostic imaging services across Welsh Health Boards.
The MOD seeks supplier input on innovative approaches to procure Naloxone and Atropine through a preliminary market engagement process open until November 2026.
